Cargando…
GABA(A) receptor occupancy by subtype selective GABA(Aα2,3) modulators: PET studies in humans
RATIONALE: Sedation, dependence, and abuse liability limit the use of non-selective γ-aminobutyric acid (GABA(A)) receptor positive modulators for the treatment of anxiety. AZD7325 and AZD6280 are novel, subtype-selective GABA(Aα2,3) receptor positive modulators with limited sedative effects. OBJECT...
Autores principales: | Jucaite, Aurelija, Cselényi, Zsolt, Lappalainen, Jaakko, McCarthy, Dennis J., Lee, Chi-Ming, Nyberg, Svante, Varnäs, Katarina, Stenkrona, Per, Halldin, Christer, Cross, Alan, Farde, Lars |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5263201/ https://www.ncbi.nlm.nih.gov/pubmed/28013354 http://dx.doi.org/10.1007/s00213-016-4506-4 |
Ejemplares similares
-
Kinetic analysis and test-retest variability of the radioligand [(11)C](R)-PK11195 binding to TSPO in the human brain - a PET study in control subjects
por: Jučaite, Aurelija, et al.
Publicado: (2012) -
PET imaging of [(11)C]PBR28 in Parkinson’s disease patients does not indicate increased binding to TSPO despite reduced dopamine transporter binding
por: Varnäs, Katarina, et al.
Publicado: (2018) -
Comparison of D(2) dopamine receptor occupancy after oral administration of quetiapine fumarate immediate-release and extended-release formulations in healthy subjects
por: Nord, Magdalena, et al.
Publicado: (2011) -
Detection of amyloid in Alzheimer’s disease with positron emission tomography using [(11)C]AZD2184
por: Nyberg, Svante, et al.
Publicado: (2009) -
Glia Imaging Shows Clinical Utility in Differentiating Parkinson's Disease from Multiple System Atrophy
por: Rinne, Juha O., et al.
Publicado: (2022)